Effects of Barley and Oat Breads on Appetite

NCT04749498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-02-15

No results posted yet for this study

Summary

This study aimed to compare the postprandial effects of ß-glucan derived from oats bread (OB) and barley bread (BB) on appetite and glycemia. A randomized, double-blind, crossover trial included 20 healthy individuals. All participants consumed BB, white bread (WB), and whole wheat bread (WWB) with a standard breakfast and then were served an ad libitum lunch on four different days. A visual analog scale (VAS) was used to assess appetite before breakfast and at 15, 30, 60, 90, 120, 150, and 180 minutes after breakfast. Blood glucose levels were measured at 0, 15, 30, 45, 60, 90, and 120 minutes. Postprandial appetite and glucose responses were quantified as the incremental area under the curve (iAUC) calculated according to the trapezoidal rule.

Conditions

  • Healthy
  • Appetitive Behavior

Interventions

OTHER

White Bread

Test breakfast with white bread was served after 12-hours of fasting and participants were asked to consume the meal in full, within 15 minutes.

OTHER

Whole Wheat Bread

In a crossover design, this bread was served with a standard breakfast to compare other breads.

OTHER

Barley Bread

In a crossover design, this bread was served with a standard breakfast to compare other breads.

OTHER

Oat Bread

In a crossover design, this bread was served with a standard breakfast to compare other breads.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Zeynep Caferoglu, PhD · Erciyes University Faculty of Health Sciences 38039 Kayseri / Turkey

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-03-01
Completion
2021-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04749498 on ClinicalTrials.gov